Citation 1: Rey MW, Woloshuk SL, deBoer HA, et al. Complete nucleotide sequence of human mammary gland lactoferrin. Nucleic Acids Res. 1990;18(17):5288. Published 1990 Sep 11. doi:10.1093/nar/18.17.5288
Citation 2: Siebert PD, Huang BC, Huang BC. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci U S A. 1997;94(6):2198-203. Published 1997 Mar 18. doi:10.1073/pnas.94.6.2198
Citation 3: Cheng H, Chen XZ, Huan LD, et al. [cDNA cloning and sequence analysis of human lactoferrin]. Sheng Wu Gong Cheng Xue Bao. 2001;17(4):385-7. Published 2001 Jul. doi:
Citation 4: Kumar J, Weber W, Münchau S, et al. Crystal structure of human seminal diferric lactoferrin at 3.4 Angstrom resolution. Indian J Biochem Biophys. 2003;40(1):14-21. Published 2003 Feb. doi:
Citation 5: Velliyagounder K, Kaplan JB, Furgang D, et al. One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis. Infect Immun. 2003;71(11):6141-7. Published 2003 Nov. doi:10.1128/IAI.71.11.6141-6147.2003
Citation 6: Ota T, Suzuki Y, Nishikawa T, et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004;36(1):40-5. Published 2004 Jan. doi:10.1038/ng1285
Citation 7: Muzny DM, Scherer SE, Kaul R, et al. The DNA sequence, annotation and analysis of human chromosome 3. Nature. 2006;440(7088):1194-8. Published 2006 Apr 27. doi:10.1038/nature04728
Citation 8: Gerhard DS, Wagner L, Feingold EA, et al. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004;14(10B):2121-7. Published 2004 Oct. doi:10.1101/gr.2596504
Citation 9: Teng CT, Liu Y, Yang N, et al. Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse. Mol Endocrinol. 1992;6(11):1969-81. Published 1992 Nov. doi:10.1210/mend.6.11.1480183
Citation 10: Powell MJ, Ogden JE, Ogden JE. Nucleotide sequence of human lactoferrin cDNA. Nucleic Acids Res. 1990;18(13):4013. Published 1990 Jul 11. doi:10.1093/nar/18.13.4013
Citation 11: Metz-Boutigue MH, Jollès J, Mazurier J, et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem. 1984;145(3):659-76. Published 1984 Dec 17. doi:10.1111/j.1432-1033.1984.tb08607.x
Citation 12: Metz-Boutigue MH, Mazurier J, Jollès J, et al. The present state of the human lactotransferrin sequence. Study and alignment of the cyanogen bromide fragments and characterization of N- and C-terminal domains. Biochim Biophys Acta. 1981;670(2):243-54. Published 1981 Sep 29. doi:10.1016/0005-2795(81)90016-7
Citation 13: Bellamy W, Takase M, Yamauchi K, et al. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta. 1992;1121(1-2):130-6. Published 1992 May 22. doi:10.1016/0167-4838(92)90346-f
Citation 14: Mann DM, Romm E, Migliorini M, et al. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J Biol Chem. 1994;269(38):23661-7. Published 1994 Sep 23. doi:
Citation 15: Sato I, Sato I. Characterization of the 84-kDa protein with ABH activity in human seminal plasma. Nihon Hoigaku Zasshi. 1995;49(5):281-93. Published 1995 Oct. doi:
Citation 16: Hunter HN, Demcoe AR, Jenssen H, et al. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob Agents Chemother. 2005;49(8):3387-95. Published 2005 Aug. doi:10.1128/AAC.49.8.3387-3395.2005
Citation 17: Azkargorta M, Soria J, Ojeda C, et al. Human Basal Tear Peptidome Characterization by CID, HCD, and ETD Followed by in Silico and in Vitro Analyses for Antimicrobial Peptide Identification. J Proteome Res. 2015;14(6):2649-58. Published 2015 Jun 5. doi:10.1021/acs.jproteome.5b00179
Citation 18: Rado TA, Wei XP, Benz EJ Jr, et al. Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis. Blood. 1987;70(4):989-93. Published 1987 Oct. doi:
Citation 19: Metz-Boutigue MH, Jollès J, Mazurier J, et al. An 88 amino acid long C-terminal sequence of human lactotransferrin. FEBS Lett. 1982;142(1):107-10. Published 1982 Jun 1. doi:10.1016/0014-5793(82)80229-9
Citation 20: Arnold RR, Russell JE, Champion WJ, et al. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect Immun. 1982;35(3):792-9. Published 1982 Mar. doi:10.1128/iai.35.3.792-799.1982
Citation 21: Cramer E, Pryzwansky KB, Villeval JL, et al. Ultrastructural localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood. 1985;65(2):423-32. Published 1985 Feb. doi:
Citation 22: Ellison RT 3rd, Giehl TJ, LaForce FM, et al. Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun. 1988;56(11):2774-81. Published 1988 Nov. doi:10.1128/iai.56.11.2774-2781.1988
Citation 23: Tani F, Iio K, Chiba H, et al. Isolation and characterization of opioid antagonist peptides derived from human lactoferrin. Agric Biol Chem. 1990;54(7):1803-10. Published 1990 Jul. doi:
Citation 24: van Berkel PH, Geerts ME, van Veen HA, et al. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J. 1997;328 ( Pt 1)(Pt 1):145-51. Published 1997 Nov 15. doi:10.1042/bj3280145
Citation 25: Lupetti A, Paulusma-Annema A, Welling MM, et al. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother. 2000;44(12):3257-63. Published 2000 Dec. doi:10.1128/AAC.44.12.3257-3263.2000
Citation 26: Abrink M, Larsson E, Gobl A, et al. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int. 2000;57(5):2004-10. Published 2000 May. doi:10.1046/j.1523-1755.2000.00050.x
Citation 27: Nibbering PH, Ravensbergen E, Welling MM, et al. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun. 2001;69(3):1469-76. Published 2001 Mar. doi:10.1128/IAI.69.3.1469-1476.2001
Citation 28: Singh PK, Parsek MR, Greenberg EP, et al. A component of innate immunity prevents bacterial biofilm development. Nature. 2002;417(6888):552-5. Published 2002 May 30. doi:10.1038/417552a
Citation 29: Liu D, Wang X, Zhang Z, et al. An intronic alternative promoter of the human lactoferrin gene is activated by Ets. Biochem Biophys Res Commun. 2003;301(2):472-9. Published 2003 Feb 7. doi:10.1016/s0006-291x(02)03077-2
Citation 30: Viejo-DÃaz M, Andrés MT, Pérez-Gil J, et al. Potassium efflux induced by a new lactoferrin-derived peptide mimicking the effect of native human lactoferrin on the bacterial cytoplasmic membrane. Biochemistry (Mosc). 2003;68(2):217-27. Published 2003 Feb. doi:10.1023/a:1022657630698
Citation 31: Hendrixson DR, Qiu J, Shewry SC, et al. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol Microbiol. 2003;47(3):607-17. Published 2003 Feb. doi:10.1046/j.1365-2958.2003.03327.x
Citation 32: Breton M, Mariller C, Benaïssa M, et al. Expression of delta-lactoferrin induces cell cycle arrest. Biometals. 2004;17(3):325-9. Published 2004 Jun. doi:10.1023/b:biom.0000027712.81056.13
Citation 33: Cornish J, Callon KE, Naot D, et al. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology. 2004;145(9):4366-74. Published 2004 Sep. doi:10.1210/en.2003-1307
Citation 34: Kim CW, Son KN, Choi SY, et al. Human lactoferrin upregulates expression of KDR/Flk-1 and stimulates VEGF-A-mediated endothelial cell proliferation and migration. FEBS Lett. 2006;580(18):4332-6. Published 2006 Aug 7. doi:10.1016/j.febslet.2006.06.091
Citation 35: Mistry N, Drobni P, Näslund J, et al. The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Res. 2007;75(3):258-65. Published 2007 Sep. doi:10.1016/j.antiviral.2007.03.012
Citation 36: Wang Z, Widgren EE, Richardson RT, et al. Characterization of an eppin protein complex from human semen and spermatozoa. Biol Reprod. 2007;77(3):476-84. Published 2007 Sep. doi:10.1095/biolreprod.107.060194
Citation 37: Johansson C, Jonsson M, Marttila M, et al. Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. J Virol. 2007;81(2):954-63. Published 2007 Jan. doi:10.1128/JVI.01995-06
Citation 38: Picariello G, Ferranti P, Mamone G, et al. Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry. Proteomics. 2008;8(18):3833-47. Published 2008 Sep. doi:10.1002/pmic.200701057
Citation 39: Bournazou I, Pound JD, Duffin R, et al. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest. 2009;119(1):20-32. Published 2009 Jan. doi:10.1172/JCI36226
Citation 40: Chen R, Jiang X, Sun D, et al. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009;8(2):651-61. Published 2009 Feb. doi:10.1021/pr8008012
Citation 41: Ando K, Hasegawa K, Shindo K, et al. Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling. FEBS J. 2010;277(9):2051-66. Published 2010 May. doi:10.1111/j.1742-4658.2010.07620.x
Citation 42: Hardivillé S, Hoedt E, Mariller C, et al. O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin. J Biol Chem. 2010;285(25):19205-18. Published 2010 Jun 18. doi:10.1074/jbc.M109.080572
Citation 43: Burkard TR, Planyavsky M, Kaupe I, et al. Initial characterization of the human central proteome. BMC Syst Biol. 2011;5:17. Published 2011 Jan 26. doi:10.1186/1752-0509-5-17
Citation 44: Mariller C, Hardivillé S, Hoedt E, et al. Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor. Biochem Cell Biol. 2012;90(3):307-19. Published 2012 Jun. doi:10.1139/o11-070
Citation 45: Bian Y, Song C, Cheng K, et al. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014;96:253-62. Published 2014 Jan 16. doi:10.1016/j.jprot.2013.11.014
Citation 46: Anderson BF, Baker HM, Norris GE, et al. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. J Mol Biol. 1989;209(4):711-34. Published 1989 Oct 20. doi:10.1016/0022-2836(89)90602-5
Citation 47: Norris GE, Anderson BF, Baker EN, et al. Molecular replacement solution of the structure of apolactoferrin, a protein displaying large-scale conformational change. Acta Crystallogr B. 1991;47 ( Pt 6):998-1004. Published 1991 Dec 1. doi:10.1107/s0108768191008418
Citation 48: Smith CA, Anderson BF, Baker HM, et al. Metal substitution in transferrins: the crystal structure of human copper-lactoferrin at 2.1-A resolution. Biochemistry. 1992;31(18):4527-33. Published 1992 May 12. doi:10.1021/bi00133a020
Citation 49: Day CL, Anderson BF, Tweedie JW, et al. Structure of the recombinant N-terminal lobe of human lactoferrin at 2.0 A resolution. J Mol Biol. 1993;232(4):1084-100. Published 1993 Aug 20. doi:10.1006/jmbi.1993.1462
Citation 50: Smith CA, Anderson BF, Baker HM, et al. Structure of copper- and oxalate-substituted human lactoferrin at 2.0 A resolution. Acta Crystallogr D Biol Crystallogr. 1994;50(Pt 3):302-16. Published 1994 May 1. doi:10.1107/S0907444994000491
Citation 51: Bourne Y, Mazurier J, Legrand D, et al. Structures of a legume lectin complexed with the human lactotransferrin N2 fragment, and with an isolated biantennary glycopeptide: role of the fucose moiety. Structure. 1994;2(3):209-19. Published 1994 Mar 15. doi:10.1016/s0969-2126(00)00022-8
Citation 52: Haridas M, Anderson BF, Baker EN, et al. Structure of human diferric lactoferrin refined at 2.2 A resolution. Acta Crystallogr D Biol Crystallogr. 1995;51(Pt 5):629-46. Published 1995 Sep 1. doi:10.1107/S0907444994013521
Citation 53: Baker HM, Anderson BF, Brodie AM, et al. Anion binding by transferrins: importance of second-shell effects revealed by the crystal structure of oxalate-substituted diferric lactoferrin. Biochemistry. 1996;35(28):9007-13. Published 1996 Jul 16. doi:10.1021/bi960288y
Citation 54: Faber HR, Baker CJ, Day CL, et al. Mutation of arginine 121 in lactoferrin destabilizes iron binding by disruption of anion binding: crystal structures of R121S and R121E mutants. Biochemistry. 1996;35(46):14473-9. Published 1996 Nov 19. doi:10.1021/bi961729g
Citation 55: Faber HR, Bland T, Day CL, et al. Altered domain closure and iron binding in transferrins: the crystal structure of the Asp60Ser mutant of the amino-terminal half-molecule of human lactoferrin. J Mol Biol. 1996;256(2):352-63. Published 1996 Feb 23. doi:10.1006/jmbi.1996.0091
Citation 56: Nicholson H, Anderson BF, Bland T, et al. Mutagenesis of the histidine ligand in human lactoferrin: iron binding properties and crystal structure of the histidine-253-->methionine mutant. Biochemistry. 1997;36(2):341-6. Published 1997 Jan 14. doi:10.1021/bi961908y
Citation 57: Jameson GB, Anderson BF, Norris GE, et al. Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change. Acta Crystallogr D Biol Crystallogr. 1998;54(Pt 6 Pt 2):1319-35. Published 1998 Nov 1. doi:10.1107/s0907444998004417
Citation 58: Sun XL, Baker HM, Shewry SC, et al. Structure of recombinant human lactoferrin expressed in Aspergillus awamori. Acta Crystallogr D Biol Crystallogr. 1999;55(Pt 2):403-7. Published 1999 Feb. doi:10.1107/s0907444998011226
Citation 59: Peterson NA, Anderson BF, Jameson GB, et al. Crystal structure and iron-binding properties of the R210K mutant of the N-lobe of human lactoferrin: implications for iron release from transferrins. Biochemistry. 2000;39(22):6625-33. Published 2000 Jun 6. doi:10.1021/bi0001224
Citation 60: Baker HM, Baker CJ, Smith CA, et al. Metal substitution in transferrins: specific binding of cerium(IV) revealed by the crystal structure of cerium-substituted human lactoferrin. J Biol Inorg Chem. 2000;5(6):692-8. Published 2000 Dec. doi:10.1007/s007750000157
Citation 61: Jameson GB, Anderson BF, Breyer WA, et al. Structure of a domain-opened mutant (R121D) of the human lactoferrin N-lobe refined from a merohedrally twinned crystal form. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 6 Pt 2):955-62. Published 2002 Jun. doi:10.1107/s0907444902005127
Citation 62: Peterson NA, Arcus VL, Anderson BF, et al. 'Dilysine trigger' in transferrins probed by mutagenesis of lactoferrin: crystal structures of the R210G, R210E, and R210L mutants of human lactoferrin. Biochemistry. 2002;41(48):14167-75. Published 2002 Dec 3. doi:10.1021/bi020443a
Citation 63: Japelj B, Pristovsek P, Majerle A, et al. Structural origin of endotoxin neutralization and antimicrobial activity of a lactoferrin-based peptide. J Biol Chem. 2005;280(17):16955-61. Published 2005 Apr 29. doi:10.1074/jbc.M500266200
Citation 64: Thomassen EA, van Veen HA, van Berkel PH, et al. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin. Transgenic Res. 2005;14(4):397-405. Published 2005 Aug. doi:10.1007/s11248-005-3233-0
Citation 65: Japelj B, Zorko M, Majerle A, et al. The acyl group as the central element of the structural organization of antimicrobial lipopeptide. J Am Chem Soc. 2007;129(5):1022-3. Published 2007 Feb 7. doi:10.1021/ja067419v
Citation 66: Senkovich O, Cook WJ, Mirza S, et al. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism. J Mol Biol. 2007;370(4):701-13. Published 2007 Jul 20. doi:10.1016/j.jmb.2007.04.075
Citation 67: Klintworth GK, Sommer JR, Obrian G, et al. Familial subepithelial corneal amyloidosis (gelatinous drop-like corneal dystrophy): exclusion of linkage to lactoferrin gene. Mol Vis. 1998;4:31. Published 1998 Dec 31. doi:
Citation 68: Videm V, Dahl H, WÃ¥lberg LE, et al. Functional polymorphisms in the LTF gene and risk of coronary artery stenosis. Hum Immunol. 2012;73(5):554-9. Published 2012 May. doi:10.1016/j.humimm.2012.02.014